Skip to main content

MoneyWorks4Me

Glenmark Life Sciences informs about offer letter

09 Feb 2024 Evaluate
Glenmark Life Sciences has informed that DAM Capital Advisors (Manager to the Offer) has submitted a copy of Letter of Offer to the Public Shareholders of Glenmark Life Sciences (Target Company).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..